'Game-changer': Tests using cerebrospinal fluid samples can help in early diagnosis of Parkinson's disease, says study
Parkinsons is the second most common neurodegenerative disease after Alzheimers and affects more than 8.5 million people worldwide, according to WHO. There is no cure or way to test for the disease, which is usually diagnosed by a doctor only once symptoms appear
Daniela Berg Christine Klein Andrew Siderowf University Of Pennsylvania Germany University Hospital Schleswig Holstein World Health Organization
Source: firstpost.com